Is QuantumScape a Buy Now?
QuantumScape (NYSE:QS) is an innovative EV battery company that specializes…
Buy
66
PATH Quote, Financials, Valuation and Earnings
Last price:
$11.94
Seasonality move
:
-6.04%
Day range:
$11.46 - $11.96
52-week range:
$9.38 - $20.95
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.68x
P/B ratio:
3.57x
Volume:
12.2M
Avg. volume:
14M
1-year change:
-37.06%
Market cap:
$6.6B
Revenue:
$1.4B
EPS (TTM):
-$0.13
PATH Analysts' Consensus Rating
The 22 analysts providing 12-month price projections for UiPath shares anticipate an average target of $12.31, ranging from a low estimate of $10.00 to a high estimate of $16.12. This average target implies a growth of 1.59% compared to the current stock price of $11.94.
Consensus Price Target
$12.31
Highest Price Target
$16.12
Lowest Price Target
$10.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 2 | 2 | 2 |
| Hold | 19 | 19 | 19 |
| Sell | 0 | 1 | 1 |
| Consensus | Hold | Hold | Hold |
PATH Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Sell
50
RGC alert for May 1
Regencell Bioscience Holdings [RGC] is up 8.33% over the past day.
Sell
38
WGS alert for May 1
GeneDx Holdings [WGS] is down 3.11% over the past day.
Sell
43
VICR alert for May 1
Vicor [VICR] is up 0.43% over the past day.
